Company
Headquarters: Clearwater, FL, United States
CEO: Dr. M. Kevin Sorrels D.D.S.
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $154.23 B |
| EssilorLuxottica SA | $98.99 B |
| Becton, Dickinson and Company | $65.82 B |
| Alcon Inc. | $43.72 B |
| HOYA Corp | $42.76 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Golden Valley Development, Inc, through its subsidiaries, manufactures and markets patented products in the health care and home consumer markets sectors. Its products include Percuguard and Cutstop used as finger guards which protect finger and thumbs from accidental cuts from knives and other sharp implements. The company is also engaged in the media consultancy practice wherein entertainment and sports industry companies, investors, personalities, and other figures are identified and brought to participate in joint venture marketing and entertainment projects being developed. Golden Valley Development, Inc was founded in 2004 and is based in Clearwater, Florida.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Golden Valley Development, Inc. has the following listings and related stock indices.
Stock: OTC: GVDI wb_incandescent